Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
Plos One
|
August 29, 2019
A modelling framework for improved design and decision-making in drug development
Stig Johan Wiklund
Journal of Biopharmaceutical Statistics
|
October 28, 2021
Do strict decision criteria hamper productivity in the pharmaceutical industry?
Stig Johan Wiklund
Mutagenesis
|
March 7, 2003
Aspects of design and statistical analysis in the Comet assay
Stig Johan Wiklund, Eva Agurell
Pharmaceutical Statistics
|
May 18, 2021
Selection bias, investment decisions and treatment effect distributions
Stig Johan Wiklund, Carl-Fredrik Burman
Pharmaceutical Statistics
|
December 14, 2011
Modelling and simulation in the pharmaceutical industry--some reflections
Carl-Fredrik Burman, Stig Johan Wiklund
Pharmaceutical Statistics
|
June 1, 2023
Replenishing the pipeline: A quantitative approach to optimising the sourcing of new projects
Stig Johan Wiklund, Magnus Önnheim, Magnus Ytterstad
Digital Biomarkers
|
August 11, 2022
Quantifying the Benefits of Digital Biomarkers and Technology-Based Study Endpoints in Clinical Trials: Project Moneyball
Hiromasa Mori, Stig Johan Wiklund, Jason Yuren Zhang
Marine Pollution Bulletin
|
October 19, 2005
Avoidance response of sediment living amphipods to zinc pyrithione as a measure of sediment toxicity
Ann-Kristin Eriksson Wiklund, Therese Börjesson, Stig Johan Wiklund
Journal of Applied Toxicology : JAT
|
March 4, 2005
Benefits of combining the sexes when evaluating data from toxicological studies
Stig Johan Wiklund, Karin Svens, Maud Palm, et al.
Environmental Toxicology and Chemistry
|
October 14, 2003
Dynamics of lipids and polychlorinated biphenyls in a Baltic amphipod (Monoporeia affinis): a field study
Ann-Kristin Eriksson Wiklund, Stig Johan Wiklund, Johan Axelman, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
Plos One
|
August 29, 2019
A modelling framework for improved design and decision-making in drug development
Stig Johan Wiklund
Journal of Biopharmaceutical Statistics
|
October 28, 2021
Do strict decision criteria hamper productivity in the pharmaceutical industry?
Stig Johan Wiklund
Mutagenesis
|
March 7, 2003
Aspects of design and statistical analysis in the Comet assay
Stig Johan Wiklund, Eva Agurell
Pharmaceutical Statistics
|
May 18, 2021
Selection bias, investment decisions and treatment effect distributions
Stig Johan Wiklund, Carl-Fredrik Burman
Pharmaceutical Statistics
|
December 14, 2011
Modelling and simulation in the pharmaceutical industry--some reflections
Carl-Fredrik Burman, Stig Johan Wiklund
Pharmaceutical Statistics
|
June 1, 2023
Replenishing the pipeline: A quantitative approach to optimising the sourcing of new projects
Stig Johan Wiklund, Magnus Önnheim, Magnus Ytterstad
Digital Biomarkers
|
August 11, 2022
Quantifying the Benefits of Digital Biomarkers and Technology-Based Study Endpoints in Clinical Trials: Project Moneyball
Hiromasa Mori, Stig Johan Wiklund, Jason Yuren Zhang
Marine Pollution Bulletin
|
October 19, 2005
Avoidance response of sediment living amphipods to zinc pyrithione as a measure of sediment toxicity
Ann-Kristin Eriksson Wiklund, Therese Börjesson, Stig Johan Wiklund
Journal of Applied Toxicology : JAT
|
March 4, 2005
Benefits of combining the sexes when evaluating data from toxicological studies
Stig Johan Wiklund, Karin Svens, Maud Palm, et al.
Environmental Toxicology and Chemistry
|
October 14, 2003
Dynamics of lipids and polychlorinated biphenyls in a Baltic amphipod (Monoporeia affinis): a field study
Ann-Kristin Eriksson Wiklund, Stig Johan Wiklund, Johan Axelman, et al.
Page
of 2